The first U.S. site with a Somatom Sensation 64 is up and running. Siemens installed the system at the Mayo Clinic in Rochester, MN, in late July. The CT will be used in research aimed at quantifying normal and abnormal physiologic function, visualizing
The first U.S. site with a Somatom Sensation 64 is up and running. Siemens installed the system at the Mayo Clinic in Rochester, MN, in late July. The CT will be used in research aimed at quantifying normal and abnormal physiologic function, visualizing early signs of disease, managing difficult-to-image patients, and reducing radiation dose.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.